shorter lengths of stay (4.0 vs. 3.1 days; p>.001) and used fewer doses of opioids (91.77 vs. 54.52 morphine equivalents; p=.012). Rates of complications were similar between groups (23.9% vs. 13.5%; p=.145). Linear regression revealed lower pain scores on postoperative day (POD) 1 and 2 and patient being out of bed on POD1 were predictive of decreased total opioid use. Factors predictive of decreased length of stay included patient out of bed on POD1, decreased total opioid use, and participation in the ERAS protocol. Increased total opioid use was predictive of increased pain scores on day of discharge.
INTRODUCTION:
Adverse perioperative events (APE) complicate 5-30% of cleft palate repairs, 1 causing significant morbidity, distress, and prolonged hospitalizations. While syndromic diagnosis and young age have been implicated as APE risk factors in general anesthesia, individual risk remains difficult to predict. This study prospectively validates a previously-developed risk assessment tool which estimates individual risk for APEs after cleft palatoplasty.
METHODS:
A prospective cohort of patients under 2 years having primary Furlow palatoplasty were reviewed for medical history and perioperative data. APEs were defined as laryngobronchospasm, accidental extubation, reintubation, obstruction, hypoxia, and unplanned ICU admission. Multivariate regression modeling, risk factor stratification, and model performance were assessed.
RESULTS:
190 patients averaging 11.7 months were included. Veau Cleft distribution included: Submucosal-13.9%, I-14.9%, II-31.4%, III-32.0%, IV-7.7%. Pierre Robin (PRS) (N=29) was the most prevalent syndrome/ anomaly. 60% of patients received paralytic reversal and total narcotic dose averaged 0.17 mg/kg. APEs occurred in 31 patients (16.3%): hypoxia (11.6%), airway obstruction (6.3%), unplanned ICU (6.3%), laryngobronchospasm (2.1%) reintubation (1.1%).
Adjusted regression analysis for APEs identified risk factors including higher perioperative narcotic administration (> 0.32 mg/kg OR=11.6, p=0.004), abnormal airway anatomy (OR=4.52, p=0.045), 2+ intubation attempts (OR=4.43, p=0.006), history of reactive airway disease (OR=4.11, p=0.029), and syndrome other than PRS (OR=2.74, p=0.05). Protective factors included administration of reversal agent (OR=0.37, p=0.05) and use of gelfoam packing (OR=0.25, p=0.04). Patients were risk-stratified according to individual profiles as low (APE: 2.1%), average (APE: 5.7%), high (APE: 37.8%), or extreme risk (APE: 88.9%). Validation against our prior predictive tool found this prospective risk model was significantly more accurate with C-statistic=0.87 vs. C-statistic=0.74 (p=0.002).
2 CONCLUSION: APEs occurred in 16.3% of palatoplasties. Higher opioid doses, multiple intubation attempts, and syndromes not including PRS imparted significant perioperative risk while use of paralytic reversal agents was consistently protective. Validated prospective risk-assessment tools such as this provide discrete strategies 3 for reducing risk and may better inform patient selection and perioperative management in an evidence-based manner. 
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CONCLUSION:
Eye tracking provides a novel and objective way to evaluate viewers' attention and to correlate gaze data with clinical aesthetic outcomes. In comparing the three techniques, the subjects' attention indicated that they tend to prefer the Fisher repair, with these images receiving the highest number of fixations, longest time of fixation, and highest Likert score. Interestingly, viewers seem to first fixate on the philtrum to establish a reference of normal anatomy before moving to examine the repair scars, as none of the repair techniques typically caught viewers' initial attention. However, viewers did tend to spend more time analyzing the scar than other areas of the face in about half of all repairs after first establishing a normal reference frame. This suggests that repair scars do capture viewers' attention but only upon a closer inspection. Ongoing work includes testing these effects on craniofacial and non-craniofacial attending surgeons and exploring the impact of bilateral repairs of each technique.
